NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue962,072811,113762,415
Cost of Revenue240,093194,479182,358
Gross Profit721,979616,634580,057
Operating Expenses
Research Development47,99935,83337,486
Selling General and Administrative533,624457,280456,700
Non Recurring-25,172-28,07854,156
Total Operating Expenses598,452477,551561,913
Operating Income or Loss123,527139,08318,144
Income from Continuing Operations
Total Other Income/Expenses Net-18,2992,014-1,443
Earnings Before Interest and Taxes105,228141,09716,701
Interest Expense40,52029,07827,911
Income Before Tax64,708112,019-11,210
Income Tax Expense29,28246,7296,286
Minority Interest5,5887,3098,310
Net Income From Continuing Ops37,14766,291-16,720
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income37,14766,291-16,720
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares37,14766,291-16,720